Dentsply International Given Neutral Rating at Zacks (XRAY)

Share on StockTwits

Dentsply International (NASDAQ:XRAY)‘s stock had its “neutral” rating reaffirmed by Zacks in a research note issued on Wednesday, StockRatingsNetwork.com reports. They currently have a $48.00 price objective on the stock. Zacks‘s price objective suggests a potential upside of 5.10% from the company’s current price.

Zacks’ analyst wrote, “DENTSPLY’s first-quarter 2014 earnings per share grew 13.5% to $0.59, beating the Zacks Consensus Estimate by $0.04. Net revenues fell 0.3% to $730.1 million and missed the Zacks Consensus Estimate of $752 million. Though U.S. recorded a modest sales growth, disappointing sales in Europe dampened revenue growth. However, we believe a diversified product range and significant investments in product innovation should help the company expand its share in the dental market. Management expects a 5.1-8.5% rise in earnings per share in 2014 based on better global market conditions. As such, we reaffirm our Neutral recommendation on DENTSPLY with a target of $48.00.”

Separately, analysts at Ned Davis Research downgraded shares of Dentsply International from a “buy” rating to a “neutral” rating in a research note on Monday, February 10th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $49.60.

Shares of Dentsply International (NASDAQ:XRAY) opened at 45.67 on Wednesday. Dentsply International has a 52-week low of $39.90 and a 52-week high of $50.99. The stock has a 50-day moving average of $45.46 and a 200-day moving average of $46.5. The company has a market cap of $6.488 billion and a P/E ratio of 21.05.

Dentsply International (NASDAQ:XRAY) last released its earnings data on Tuesday, May 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.03. The company had revenue of $730.10 million for the quarter, compared to the consensus estimate of $747.27 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was down .3% on a year-over-year basis. Analysts expect that Dentsply International will post $2.52 EPS for the current fiscal year.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Brewing Beer the Belgium Way
Brewing Beer the Belgium Way
White House Announces Majority of Children to Be Returned
White House Announces Majority of Children to Be Returned
More Immigrants Anticipated in Southern California
More Immigrants Anticipated in Southern California
Dark Chocolate Might Ease Impact of Artery Disease
Dark Chocolate Might Ease Impact of Artery Disease
Smartphones Come Before Chocolate or Alcohol
Smartphones Come Before Chocolate or Alcohol
Thousands of Deaths in U.S. Linked to Excessive Drinking
Thousands of Deaths in U.S. Linked to Excessive Drinking


Leave a Reply

 
© 2006-2014 The Legacy. Subscribe